Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cecilie, Budolfsen"'
Autor:
Nils E. Magnusson, Cecilie Budolfsen, Johann Bauer, Marcus Krüger, Daniela Grimm, Julie Faber, Markus Wehland, Manfred Infanger
Publikováno v:
Budolfsen, C, Faber, J, Grimm, D, Krüger, M, Bauer, J, Wehland, M, Infanger, M & Magnusson, N E 2019, ' Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment ', Current Vascular Pharmacology, vol. 17, no. 6, pp. 618-634 . https://doi.org/10.2174/1570161117666190130165810
Cancer treatment is an area of continuous improvement. Therapy is becoming more targeted and the use of anti-angiogenic agents in multiple cancers, specifically tyrosine kinase inhibitors (TKIs), has demonstrated prolonged survival outcomes compared
Autor:
Manfred Infanger, Markus Wehland, Cecilie Budolfsen, Daniela Grimm, Nils E. Magnusson, Marcus Krüger, Nanna Bæk Møller
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 19, p 4712 (2019)
Bæk Møller, N, Budolfsen, C, Grimm, D, Krüger, M, Infanger, M, Wehland, M & E Magnusson, N 2019, ' Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment ', International Journal of Molecular Sciences, vol. 20, no. 19, 4712 . https://doi.org/10.3390/ijms20194712
International Journal of Molecular Sciences
Bæk Møller, N, Budolfsen, C, Grimm, D, Krüger, M, Infanger, M, Wehland, M & E Magnusson, N 2019, ' Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment ', International Journal of Molecular Sciences, vol. 20, no. 19, 4712 . https://doi.org/10.3390/ijms20194712
International Journal of Molecular Sciences
This paper reviews current treatments for renal cell carcinoma/cancer (RCC) with the multikinase inhibitors (MKIs) sorafenib, sunitinib, lenvatinib and axitinib. Furthermore, it compares these drugs regarding progression-free survival, overall surviv
Autor:
Cecilie Budolfsen, Dung T Nguyen, Kasper G Lauridsen, Mathilde Stærk, Anders S Schmidt, Bo Løfgren
Publikováno v:
Circulation. 138
Introduction: Automated external defibrillators (AEDs) should be easy to use to improve survival from cardiac arrest. In pediatric cardiac arrest, defibrillation is recommended to be delivered with less energy compared with adults. Consequently, many
Autor:
Cecilie, Budolfsen, T, Nguyen Dung, G, Lauridsen Kasper, Mathilde, Stærk, S, Schmidt Anders, Bo, Løfgren
Publikováno v:
Cecilie, B, T, N D, G, L K, Mathilde, S, S, S A & Bo, L 2018, ' Major Differences in the Intended Operation and Default Energy Setting in Automated External Defibrillators in Pediatric Cardiac Arrest ', Circulation, bind 138, nr. Suppl_2, s. A162-A162 . https://doi.org/10.1161/circ.138.suppl_2.162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pure_au_____::b9fb43091c82af1d1fae9b169aa9ca4d
https://pure.au.dk/portal/da/publications/major-differences-in-the-intended-operation-and-default-energy-setting-in-automated-external-defibrillators-in-pediatric-cardiac-arrest(38adf373-abe0-4127-98d7-3a38e998275f).html
https://pure.au.dk/portal/da/publications/major-differences-in-the-intended-operation-and-default-energy-setting-in-automated-external-defibrillators-in-pediatric-cardiac-arrest(38adf373-abe0-4127-98d7-3a38e998275f).html